Skip to main content
Raphael Borok, MD, Pathology, Downers Grove, IL

RaphaelZ.BorokMDMEng

Pathology Downers Grove, IL

Hematopathology, Molecular Genetics, Anatomic Pathology, Clinical Pathology

Chairman and Medical Director

Dr. Borok is on Doximity

As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.

  • Connect with other colleagues in the same hospital or clinic
  • Search all U.S. specialist profiles and refer a patient
  • Read the latest clinical news and earn CME/CEU credits

See Dr. Borok's full profile

Already have an account?

Education & Training

  • University of Illinois
    University of IllinoisMEng, Bioinformatics and Computational Biology, 2013 - 2015
  • University of Washington
    University of WashingtonNG, Statistical Genetics (I & II), 2012 - 2013
  • Rush University Medical Center
    Rush University Medical CenterResidency, Pathology-Anatomic and Clinical, 1992 - 1997
  • University of South Africa
    University of South AfricaBSc, Mathematics and Statistics, Cum Laude, 1990
  • University of Pretoria Faculty of Medicine
    University of Pretoria Faculty of MedicineClass of 1981, MBBCh

Certifications & Licensure

  • IL State Medical License
    IL State Medical License 1992 - 2026
  • American Board of Pathology Anatomic Pathology & Clinical Pathology

Publications & Presentations

PubMed

Abstracts/Posters

  • A paradigm shift in myelodysplastic syndromes leads to novel anticytokine therapy.
    Raza A, Gezer S, Venugopal P, Shetty V, Mundle S, Chopra H, Span B, Dar S, Alvi S, Borok R, Gregory S, Priesler H, Cancer in the Elderly 1996 Conference, Tampa, FL, 11/13/1996
  • Effect of antiphosphatidic drugs on the expression of cytokines in Myelodysplastic Syndromes (MDS).
    Shetty V, Dar S, Hussaini S, Alvi S, Span L, Mundle S, Gezer S, Gregory S, Venugopal P, Hines C, Chopra H, Borok R, Robin E, Rifkin S, Alston D, Hernandez B, Hsu WT, P..., 25th Annual Meeting of the International Society for Experimental Hematology, 8/23/1996
  • The stem cell disorder in myelodysplastic syndromes is further confounded by complex cytokine effects in a study of 109 patients.
    Raza A, Dar S, Gezer S, Gregory S, Venugopal P, Hines C, Mundle S, Shetty V, Span L, Chopra H, Alvi S, Borok R, Robin E, Rifkin S, Alston D, Hernandez B, Hsu WT, Preis..., 25th Annual Meeting of the International Society for Experimental Hematology, 8/23/1996
  • Join now to see all